Over the past 30 years, dramatic advances in the understanding of HIV infection and its therapy have transformed HIV into a highly treatable, chronic disease. With this evolution, critical questions have arisen about how basic research and clinical trials relate to clinical epidemiology and outcomes research, both in the U.S. and internationally. The goal of the Program for AIDS Clinical Research Training (PACRT), which has successfully trained leading HIV clinical investigators for the past 20 years, is to provide training in quantitative research methodologies with a focus on HIV clinical research to predoctoral PhD students and physicians at formative stages in their careers. This training has prepared both groups: to conduct clinical research of the highest quality and of direct relevance to the prevention and treatment of HIV infection. They will make important contributions to the scientific literature and successfully develop as independent investigators. In the next grant cycle, the PACRT candidates will receive two years of research training under the close supervision and mentorship of one or more of the 14 experienced program faculty members. Trainees will receive didactic training at Harvard School of Public Health or other Harvard University sites. Primary performance sites for the five post-doctoral fellows will be the Massachusetts General Hospital, Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, Children's Hospital Boston and Harvard Medical School. The primary site for the two predoctoral fellows will be the Harvard School of Public Health. This program has three specific aims for its trainees: 1) To acquire a sufficient body of knowledge of quantitative methods to conduct independent research in: clinical epidemiology, clinical trials, cost-effectiveness analysis, outcomes research, and/or implementation science. 2) To foster the creation of important scientific contributions with the close and longitudinal mentorship of program faculty. 3) To develop a primary research focus and a broad understanding of the various aspects of HIV disease for novel interdisciplinary research. Relevance: PACRT has a clearly defined and unique direction among HIV T32 programs, with its focus on clinical outcomes research, and how that research interfaces with translational research, clinical trials, and health policy. This program will play a crucial role in training the next generation of highly successful investigators to address the complex issues arising today in HIV clinical research.

Public Health Relevance

The Program for AIDS Clinical Research Training (PACRT) continues to develop and launch a new cadre of independent scientists studying a broad array of clinical and public health issues in HIV disease using the tools of clinical epidemiology, outcomes research, and cost-effectiveness analysis. These young investigators focus time, energy and training on critical and evolving questions at the forefront of HIV clinical management throughout the world.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Acquired Immunodeficiency Syndrome Research Review Committee (AIDS)
Program Officer
Sharma, Opendra K
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Harvard University
Public Health & Prev Medicine
Schools of Public Health
United States
Zip Code
Ramirez-Avila, Lynn; Regan, Susan; Chetty, Senica et al. (2015) HIV testing rates, prevalence, and knowledge among outpatients in Durban, South Africa: Time trends over four years. Int J STD AIDS 26:704-9
Drain, Paul K; Losina, Elena; Coleman, Sharon M et al. (2015) Value of urine lipoarabinomannan grade and second test for optimizing clinic-based screening for HIV-associated pulmonary tuberculosis. J Acquir Immune Defic Syndr 68:274-80
Chan, Brian T; Weiser, Sheri D; Boum, Yap et al. (2015) Persistent HIV-related stigma in rural Uganda during a period of increasing HIV incidence despite treatment expansion. AIDS 29:83-90
Chan, Brian T; Weiser, Sheri D; Boum, Yap et al. (2015) Declining prevalence of probable depression among patients presenting for antiretroviral therapy in rural Uganda: the role of early treatment initiation. AIDS Behav 19:19-26
Sreeramareddy, C T; Qin, Z Z; Satyanarayana, S et al. (2014) Delays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review. Int J Tuberc Lung Dis 18:255-66
Andrews, Jason R; Morrow, Carl; Walensky, Rochelle P et al. (2014) Integrating social contact and environmental data in evaluating tuberculosis transmission in a South African township. J Infect Dis 210:597-603
Drain, Paul K; Mosam, Anisa; Gounder, Lilishia et al. (2014) Recurrent giant molluscum contagiosum immune reconstitution inflammatory syndrome (IRIS) after initiation of antiretroviral therapy in an HIV-infected man. Int J STD AIDS 25:235-8
Bassett, Ingrid V; Govindasamy, Darshini; Erlwanger, Alison S et al. (2014) Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness. PLoS One 9:e85197
Schwenk, Hayden; Ramirez-Avila, Lynn; Sheu, Shu-Hsien et al. (2014) Progressive multifocal leukoencephalopathy in pediatric patients: case report and literature review. Pediatr Infect Dis J 33:e99-105
Drain, Paul K; Losina, Elena; Coleman, Sharon M et al. (2014) Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study. BMC Infect Dis 14:110

Showing the most recent 10 out of 70 publications